IMA Related Analyst Ratings
-
Capstone initiates Coverage on Inverness Medical Innovations (IMA) with a Buy
-
Canaccord Adams Raises Price Target On Inverness Medical (IMA) to $49, Citing Pima System
-
Canaccord Adams Adds Inverness Medical Innovations (IMA) to 'Best Ideas' List; Raises Price Target & Estimates
-
ThinkEquity Initiates Coverage on Inverness Medical (IMA) with a Buy
-
Avondale Starts Inverness Medical (IMA) at Market Outperform
-
Matrix USA Rating Changes 9/15
-
Canaccord Adams Starts Inverness Medical Innovations (IMA) at Buy
-
Matrix USA Rating Changes 5/21
-
Matrix USA Rating Changes 5/9
-
Matrix USA Rating Changes 4/24
-
Merrill Lynch Initiates Coverage Inverness Medical Innovations (IMA) with a Buy
-
Matrix USA Rating Changes 11/20
-
Piper Jaffray upgrades Biosite Incorporated (BSTE) to Market Perform
-
Stifel Nicolaus Upgrades Inverness Medical Innovations (IMA) to Buy
-
Stifel Nicolaus downgrades Inverness Medical Innovations (IMA) to Hold
-
Soleil downgrades BABY to Hold
-
Jefferies Group Started IMA at Buy; $32 trgt
Back to IMA Stock Lookup
